Your browser doesn't support javascript.
loading
Small-Molecule Activators of Glucose-6-phosphate Dehydrogenase (G6PD) Bridging the Dimer Interface.
Raub, Andrew G; Hwang, Sunhee; Horikoshi, Naoki; Cunningham, Anna D; Rahighi, Simin; Wakatsuki, Soichi; Mochly-Rosen, Daria.
Afiliação
  • Raub AG; Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
  • Hwang S; Department of Chemistry, Stanford University, Stanford, CA, 94305, USA.
  • Horikoshi N; Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
  • Cunningham AD; Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance, University of Tsukuba, Ibaraki, 305-8575, Japan.
  • Rahighi S; Department of Structural Biology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
  • Wakatsuki S; Biosciences Division, SLAC National Laboratory, Menlo Park, CA, 94025, USA.
  • Mochly-Rosen D; Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
ChemMedChem ; 14(14): 1321-1324, 2019 07 17.
Article em En | MEDLINE | ID: mdl-31183991
ABSTRACT
We recently identified AG1, a small-molecule activator that functions by promoting oligomerization of glucose-6-phosphate dehydrogenase (G6PD) to the catalytically competent forms. Biochemical experiments indicate that the activation of G6PD by the original hit molecule (AG1) is noncovalent and that one C2 -symmetric region of the G6PD homodimer is important for ligand function. Consequently, the disulfide in AG1 is not required for activation of G6PD, and a number of analogues were prepared without this reactive moiety. Our study supports a mechanism of action whereby AG1 bridges the dimer interface at the structural nicotinamide adenine dinucleotide phosphate (NADP+ ) binding sites of two interacting G6PD monomers. Small molecules that promote G6PD oligomerization have the potential to provide a first-in-class treatment for G6PD deficiency. This general strategy could be applied to other enzyme deficiencies in which control of oligomerization can enhance enzymatic activity and/or stability.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ativadores de Enzimas / Glucosefosfato Desidrogenase / Indóis Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ativadores de Enzimas / Glucosefosfato Desidrogenase / Indóis Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article